StockNews.com started coverage on shares of Aethlon Medical (NASDAQ:AEMD – Free Report) in a research report sent to investors on Thursday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.
Aethlon Medical Trading Down 3.0 %
NASDAQ:AEMD opened at $0.39 on Thursday. The company’s 50 day moving average price is $0.40 and its 200-day moving average price is $0.57. Aethlon Medical has a 52 week low of $0.24 and a 52 week high of $2.35.
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last issued its earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.44) by $0.10. During the same period in the previous year, the company earned ($1.30) EPS. Sell-side analysts expect that Aethlon Medical will post -1.1 EPS for the current year.
Aethlon Medical Company Profile
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Recommended Stories
- Five stocks we like better than Aethlon Medical
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
- Why is the Ex-Dividend Date Significant to Investors?
- Apple Earnings – When Really Good Just Isn’t Good Enough
- Insider Buying Explained: What Investors Need to Know
- Starbucks Stock Primed for Growth Under New CEO Niccol’s Vision
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
